Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

GERMANTOWN, Md., May 7, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release first quarter 2026...